💊 Moderna Boosts STEM Education with Free mRNA Course, as Immutep Rises on Promising First-In-Human Trial | Biotech Sector Insights
Moderna Inc (MRNA) also contributed positively after announcing a partnership with Coursera to launch a free online course on mRNA technology, aimed at enhancing education in STEM fields.
Welcome to the MarketReader Minute.
Below are AI-generated insights on moves in the health care/biotechnology sector, powered by MarketReader technology.
Wednesday, August 14
IBB [-0.5%]
The iShares Biotechnology ETF (IBB) has experienced a price decrease. Key contributors to this performance include Illumina Inc (ILMN), which saw a notable rise following multiple upgrades from Barclays, RBC, and TD Securities, reflecting strong confidence in its long-term strategy. Moderna Inc (MRNA) also contributed positively after announcing a partnership with Coursera to launch a free online course on mRNA technology, aimed at enhancing education in STEM fields. Other significant performers included GMAB, ASND, and CRSP, all of which posted increases.